Good article from "Seeking Alpha" [which is rare] highlighting the differences between safety and potential potency advantages of Ted over Line. The author has it 100% right. Doesn't happen that often in biotech reporting.
Sentiment: Strong Buy
nerd, the price action and volume are puzzling.
I have lost confidence in SA. Check out authors before reading---some are OK.
all of Smiths stuff on his site is well done and great DD